These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 18220761)

  • 1. Virtual screening and its integration with modern drug design technologies.
    Guido RV; Oliva G; Andricopulo AD
    Curr Med Chem; 2008; 15(1):37-46. PubMed ID: 18220761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening for the discovery of bioactive natural products.
    Rollinger JM; Stuppner H; Langer T
    Prog Drug Res; 2008; 65():211, 213-49. PubMed ID: 18084917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modern drug discovery technologies: opportunities and challenges in lead discovery.
    Guido RV; Oliva G; Andricopulo AD
    Comb Chem High Throughput Screen; 2011 Dec; 14(10):830-9. PubMed ID: 21843147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive QSAR modeling workflow, model applicability domains, and virtual screening.
    Tropsha A; Golbraikh A
    Curr Pharm Des; 2007; 13(34):3494-504. PubMed ID: 18220786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular descriptors and methods for ligand based virtual high throughput screening in drug discovery.
    Pozzan A
    Curr Pharm Des; 2006; 12(17):2099-110. PubMed ID: 16796558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of computer-aided drug design in modern drug discovery.
    Macalino SJ; Gosu V; Hong S; Choi S
    Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
    Honório KM; Moda TL; Andricopulo AD
    Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current trends in virtual high throughput screening using ligand-based and structure-based methods.
    Sukumar N; Das S
    Comb Chem High Throughput Screen; 2011 Dec; 14(10):872-88. PubMed ID: 21843144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic generation of chemical structures for rational drug design based on QSAR models.
    Funatsu K; Miyao T; Arakawa M
    Curr Comput Aided Drug Des; 2011 Mar; 7(1):1-9. PubMed ID: 20550510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function and structure-based screening of compounds, peptides and proteins to identify drug candidates.
    Malik V; Dhanjal JK; Kumari A; Radhakrishnan N; Singh K; Sundar D
    Methods; 2017 Dec; 131():10-21. PubMed ID: 28843611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment-based QSAR: perspectives in drug design.
    Salum LB; Andricopulo AD
    Mol Divers; 2009 Aug; 13(3):277-85. PubMed ID: 19184499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational approaches for ligand discovery and design in class-A G protein- coupled receptors.
    Rodríguez D; Gutiérrez-de-Terán H
    Curr Pharm Des; 2013; 19(12):2216-36. PubMed ID: 23016842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual high-throughput screening of molecular databases.
    Seifert MH; Kraus J; Kramer B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):298-307. PubMed ID: 17554856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Computational chemistry in structure-based drug design].
    Cao R; Li W; Sun HZ; Zhou Y; Huang N
    Yao Xue Xue Bao; 2013 Jul; 48(7):1041-52. PubMed ID: 24133970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From drug target to leads--sketching a physicochemical pathway for lead molecule design in silico.
    Shaikh SA; Jain T; Sandhu G; Latha N; Jayaram B
    Curr Pharm Des; 2007; 13(34):3454-70. PubMed ID: 18220783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
    Wang T; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cheminformatic toolkit for mining biomedical knowledge.
    Rosania GR; Crippen G; Woolf P; States D; Shedden K
    Pharm Res; 2007 Oct; 24(10):1791-802. PubMed ID: 17385012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.